CARFILZOMIB

28379 reported adverse events

Drug classes: Proteasome Inhibitor [EPC]

These side effects are most commonly reported by patients taking CARFILZOMIB:

# Side effect Count
0 PLASMA CELL MYELOMA 3057
1 OFF LABEL USE 2413
2 DEATH 1768
3 THROMBOCYTOPENIA 1551
4 FATIGUE 1549
5 PNEUMONIA 1398
6 PYREXIA 1176
7 DIARRHOEA 1135
8 NEUTROPENIA 1127
9 DYSPNOEA 1122
See all common reactions for CARFILZOMIB

CARFILZOMIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SARS-COV-2 SEPSIS 15 0.4167
1 CEREBELLAR HAEMANGIOMA 9 0.3750
2 PLASMA CELL MYELOMA REFRACTORY 472 0.3528
3 LYMPHODEPLETION 10 0.2941
4 GLOBAL LONGITUDINAL STRAIN ABNORMAL 14 0.2545
5 PLASMA CELL LEUKAEMIA 120 0.2000
6 PLASMA CELLS INCREASED 14 0.1918
7 MYELOMA CAST NEPHROPATHY 23 0.1620
8 LIGHT CHAIN DISEASE 23 0.1586
9 PLASMACYTOMA 191 0.1025
See all enriched reactions for CARFILZOMIB